Co-exhibition in 2017 New Cardiovascular Horizons (NCVH) Annual Conference
Release time:
2017-05-09
May 10, 2017—BrosMed will co-exhibit her PTCA and PTA products family with strategic partner US Endovascular in upcoming the 2017 New Cardiovascular Horizons (NCVH) Annual Conference in New Orleans, May 31-June 02. NCVH is the international, multispecialty conference showcasing excellence in vascular medicine and intervention.
Co-exhibition in 2017 New Cardiovascular Horizons (NCVH) Annual Conference
May 10, 2017—BrosMed will co-exhibit her PTCA and PTA products family with strategic partner US Endovascular in upcoming the 2017 New Cardiovascular Horizons (NCVH) Annual Conference in New Orleans, May 31-June 02. NCVH is the international, multispecialty conference showcasing excellence in vascular medicine and intervention.
About New Cardiovascular Horizons
NCVH is an educational nonprofit foundation focused on multidisciplinary accredited conferences to advance the field of cardiovascular care using endovascular technologies, pharmacotherapy treatments, peripheral interventions and amputation prevention techniques. With a goal to empower healthcare providers with knowledge of head-to-toe vascular treatments, NCVH strives to promote interdisciplinary teamwork and collaboration to address the continuum of patient care.
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
BrosMed Medical product portfolio consist of, Artimes™ PTCA, Apollo™ NC PTCA, Atropos™ 0.035 PTA, Minerva™ 0.018 PTA, Polux™ 0.014 PTA, Hermes™ NC 0.035 PTA, Achilles™ NC 0.018 PTA, Castor™ NC 0.014 PTA, Conger™ Hydrophilic coated wire and Freepath™ Catheter Sheath Introducer. BrosMed Medical is supplying safe, effective and hi-tech medical devices in 30 countries.
About US Endovascular (USE)
US Endovascular (USE) is engaged in the procurement, licensing & distribution of medical device products used in peripheral endovascular and coronary procedures. The fundamental premise is to obtain next-generation, clinically-relevant products from manufacturers and market directly to the end user/ economic buyer. This approach eliminates all unnecessary layers, significantly reducing cost.
USE product portfolio includes: next-generation peripheral arterial laser technology (pending FDA 510k approval); next-generation PTA and PTCA balloon technology; peripheral guide wires. These product segments are used in greater than 95% of peripheral and endovascular and coronary procedures.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27